Evidence map›Paper›PMID 31163644›Full record

ArticleMedicines (Basel, Switzerland)2019

Screening of Crude Drugs Used in Japanese Kampo Formulas for Autophagy-Mediated Cell Survival of the Human Hepatocellular Carcinoma Cell Line.

Shinya Okubo, Hisa Komori, Asuka Kuwahara, Tomoe Ohta, Yukihiro Shoyama, Takuhiro Uto

Abstract read
In one paragraph

Article in Medicines (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Steroidal Saponins Isolated from the Rhizome ofLife (Basel, Switzerland) · 2021
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shinya OkuboDepartment of Pharmacognosy, Graduate School of Pharmaceutical Sciences, Nagasaki International University, Nagasaki 859-3298, Japan. shinyaokubo6252@yahoo.co.jp.
Hisa KomoriDepartment of Pharmacognosy, Faculty of Pharmaceutical Sciences, Nagasaki International University, Nagasaki 859-3298, Japan. tu19780217@gmail.com.
Asuka KuwaharaDepartment of Pharmacognosy, Faculty of Pharmaceutical Sciences, Nagasaki International University, Nagasaki 859-3298, Japan. usa6050kuwa@gmail.com.
Tomoe OhtaDepartment of Pharmacognosy, Faculty of Pharmaceutical Sciences, Nagasaki International University, Nagasaki 859-3298, Japan. ohta@niu.ac.jp.
Yukihiro ShoyamaDepartment of Pharmacognosy, Faculty of Pharmaceutical Sciences, Nagasaki International University, Nagasaki 859-3298, Japan. shoyama@niu.ac.jp.
Takuhiro UtoDepartment of Pharmacognosy, Graduate School of Pharmaceutical Sciences, Nagasaki International University, Nagasaki 859-3298, Japan. uto@niu.ac.jp.

Funding

Sasakawa Scientific Research Grant from The Japan Science Society no number
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

autophagic activitycell viabilitycrude drugsHepG2Kampo medicinesLC3-IIp62screening

Identifiers

PMID31163644
PMCPMC6631990

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.